Back

The efficacy and safety of mineralocorticoid-receptor antagonists: spironolactone and eplerenone in resistant hypertension and chronic kidney disease stages 3

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Hypertension treatment: drugs and devices Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mrs Oksana Obertynska

National Pirogov Memorial Medical University, Vinnitsa (Ukraine)

14 More presentations in this session

Presentation thumbnail
Doctor R. Hmazzou (Paris, FR)
Abstract
Presentation thumbnail
Doctor K. Bapatla (Hyderabad, IN)
Abstract Slides
Presentation thumbnail
Doctor C. Helten (Duesseldorf, DE)
Abstract
Presentation thumbnail
Doctor E. Chowdhury (Perth, AU)
Abstract Slides
Presentation thumbnail
Doctor F. Chacon-Lozsan (Budapest, HU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Hypertension treatment: drugs and devices

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Congress Presentation
Blood pressure should be lowered as low as possible - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources